Publications

Circulating Tumor Cell Assay to Non-Invasively Evaluate PD-L1 and Other Therapeutic Targets in Multiple Cancers.

Author: Page R
Datar Cancer Genetics
Published Date: June 17, 2022

PDF

PD-L1 profiling of circulating tumor cells for immune checkpoint inhibitor therapy in gastroesophageal cancers.

Author: Devhare P
Datar Cancer Genetics
Published Date: February 04, 2020

PD-L1 profiling of circulating tumor cells for immune checkpoint inhibitor therapy in head and neck cancers.

Author: Patil R
Datar Cancer Genetics
Published Date: February 04, 2020

PD-L1 profiling of circulating tumour cells is a viable companion diagnostic for checkpoint inhibitor therapy in lung cancer.

Author: Patil R
Datar Cancer Genetics
Published Date: December, 2019

To know more about Publications and Abstracts, please click here…